SCHEMBL6580073

SCHEMBL6580073

CC(C)CC(N(C)C)C(O)(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.41
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP2D6 P10635 2/20 0.37
HSD17B10 Q99714 1/20 0.37
SLC6A2 P23975 2/20 0.36
TAAR1 Q96RJ0 1/20 0.36
FDPS P14324 2/20 0.36
OPRK1 P41145 3/20 0.35
OPRM1 P35372 2/20 0.35
OPRD1 P41143 2/20 0.35
KCNH2 Q12809 3/20 0.35
HTR2A P28223 2/20 0.35
ADRA1A P35348 2/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580062 1.00 TRPA1 (0.41) TRPA1CYP2C19CYP1A2CYP2C9CRHBP
SCHEMBL6577676 0.83 OPRK1 (0.43) TRPA1CYP2C19CYP1A2CYP2C9ALDH1A1
SCHEMBL6577672 0.83 OPRK1 (0.43) TRPA1CYP2C19CYP1A2CYP2C9ALDH1A1
SCHEMBL6577654 0.79 TRPA1 (0.46) TRPA1CYP2C19CYP1A2CYP2C9CRHBP
SCHEMBL6577648 0.79 TRPA1 (0.46) TRPA1CYP2C19CYP1A2CYP2C9CRHBP
SCHEMBL1153513 0.76 LNPEP (0.44) TRPA1CYP2C19CYP1A2CYP2C9CYP2D6
SCHEMBL1153511 0.76 LNPEP (0.44) TRPA1CYP2C19CYP1A2CYP2C9CYP2D6
SCHEMBL11102570 0.75 TAAR1 (0.43) TRPA1CYP2C19CYP1A2CYP2C9CYP2D6
SCHEMBL4445459 0.74 TRPA1 (0.52) TRPA1CYP2C19CYP1A2CYP2C9CYP2D6
SCHEMBL6575422 0.73 HTR2A (0.45) CYP1A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040236118-A1 Pyrrolidine derivatives and method of synthesizing these EIZAI CO., LTD (JP) 2004-11-25 US disclosed
EP-1413574-A1 PYRROLIDINE DERIVATIVES AND METHOD OF SYNTHESIZING THESE Eizai Co., Ltd. (JP) 2004-04-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040236118-A1 Pyrrolidine derivatives and method of synthesizing these ADH1C, ADH5, ADH1A TRPA1 4750/4885CYP2C19 1076/4885CYP1A2 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.